QSTPPULSE
← Portfolio metrics

RapidDx Biotech

Full IncubationHealthHumanGrowthAt risk · MRR stalled 3 months

NorTest — rapid diagnostic platform for Norovirus using europium nanoparticles and portable readers. Impact: Public Health Protection Sector: HealthTech

MRR · latest

$94.5K

↑ +7%6mo on chart
min $73.8Kmax $94.5K

Funding · cumulative

$2.5M

min $1.8Mmax $2.5M

Runway

21 mo

above safe threshold
min 14momax 21mo

Headcount

9

↑ +13%
min 6max 9

MRR over time

Funding raised (cumulative)

Runway · months

Stage progression

Idea
Pre-Rev
Early Revenue
Growth
Scale
  • → Growth· Jun 25 · MRR $32477 or funding $1600000

Wins · blockers · last 6 months

  1. May 26

    Win:Prototype shipped

  2. Apr 26

    Win:Operational improvements landed

  3. Mar 26

    Win:New partnership signed

    Ask:Talent hiring help

  4. Feb 26

    Win:Customer growth this period

  5. Jan 26

    Win:New partnership signed

  6. Dec 25

    Win:New partnership signed

    Ask:No major asks